Catalyst Pharmaceutical
CPRX
CPRX
259 hedge funds and large institutions have $1.45B invested in Catalyst Pharmaceutical in 2023 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 82 increasing their positions, 93 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
5.55% more ownership
Funds ownership: 75.51% → 81.06% (+5.5%)
2% more funds holding
Funds holding: 255 → 259 (+4)
12% less repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 93
Holders
259
Holding in Top 10
6
Calls
$3.62M
Puts
$1.44M
Top Buyers
| 1 | +$50.6M | |
| 2 | +$23.2M | |
| 3 | +$12.3M | |
| 4 |
DM
Deerfield Management
New York
|
+$11.7M |
| 5 |
Man Group
London,
United Kingdom
|
+$10.8M |
Top Sellers
| 1 | -$13.2M | |
| 2 | -$6M | |
| 3 | -$5.38M | |
| 4 |
Millennium Management
New York
|
-$2.72M |
| 5 |
Rafferty Asset Management
New York
|
-$2.66M |